# Gynecologic Oncology Group

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/gynecologic-oncology-group/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 72.4 |
| Citations | 687,198 |
| City | Crofton |
| Country | US |
| Description | Gynecologic Oncology Group is a research organisation in Crofton, US. OpenAlex records 4,352 works and 687,198 citations for it. 938 researchers list it as their most recent affiliation. |
| Homepage | http://www.gog.org/ |
| OpenAlex ID | https://openalex.org/I117693200 |
| Researchers | 938 |
| ROR ID | https://ror.org/04x187e69 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q5625184 |
| Works | 4,352 |

## University papers

Showing 12 of 75.

- [Whole genomes redefine the mutational landscape of pancreatic cancer](https://scholariq.org/papers/whole-genomes-redefine-the-mutational-landscape-of-pancreatic-cancer/)
- [Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer](https://scholariq.org/papers/neoadjuvant-chemotherapy-or-primary-surgery-in-stage-iiic-or-iv-ovarian-cancer/)
- [Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer](https://scholariq.org/papers/niraparib-maintenance-therapy-in-platinum-sensitive-recurrent-ovarian-cancer/)
- [Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer](https://scholariq.org/papers/niraparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/)
- [Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer](https://scholariq.org/papers/olaparib-plus-bevacizumab-as-first-line-maintenance-in-ovarian-cancer/)
- [Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-iii-trial-of-carboplatin-and-paclitaxel-compared-with-cisplatin-and/)
- [ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma](https://scholariq.org/papers/esgo-estro-esp-guidelines-for-the-management-of-patients-with-endometrial/)
- [Epithelial ovarian cancer](https://scholariq.org/papers/epithelial-ovarian-cancer/)
- [Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer](https://scholariq.org/papers/olaparib-maintenance-therapy-in-platinum-sensitive-relapsed-ovarian-cancer/)
- [Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/olaparib-tablets-as-maintenance-therapy-in-patients-with-platinum-sensitive/)
- [Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/rucaparib-maintenance-treatment-for-recurrent-ovarian-carcinoma-after-response/)
- [Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial](https://scholariq.org/papers/bevacizumab-combined-with-chemotherapy-for-platinum-resistant-recurrent-ovarian/)

## University researchers

- [Ignace Vergote](https://scholariq.org/researchers/ignace-vergote/)
- [Joshua M. Cohen](https://scholariq.org/researchers/joshua-m-cohen/)
- [Thomas Kolben](https://scholariq.org/researchers/thomas-kolben/)

## University top topics

Showing 8 of 25.

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [Endometriosis Research and Treatment](https://scholariq.org/topics/endometriosis-research-and-treatment/)
- [Gynecological conditions and treatments](https://scholariq.org/topics/gynecological-conditions-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.